Single-Cell
Genome Sequencing Market study is providing you with the up-to-date,
actionable market information and projections with the latest impact of the
Covid 19 outbreak. It offers all the requisite data to support tactical
business decisions and come up with strategic growth plans. This study also
proposes a comprehensive insight into the development policies and plans in
addition to manufacturing processes and cost structures.
The global single-cell
genome sequencing market size is expected to reach USD 2.49 billion by 2025.
Single-cell genome sequencing implies analyzing the sequence data with enhanced
next-generation sequencing proficiency from a cell. It is a potent instrument
that aims to offer intelligence and understanding of genetics by carrying the
examination of genomes to the cellular stage. The single-cell genome sequencing
technique has a vast effect on various fields of biology comprising cancer
research, immunology microbiology, neurobiology, and tissue mosaicism.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/single-cell-genome-sequencing-market/request-sample
Factors such as high cost,
and analytical challenges in measurement of the single molecule of DNA may
hinder the development of the market in the years to come. The Single-cell
genome sequencing market is anticipated to grow at a significant CAGR of 14.6%
in the upcoming period as the scope, product types and its applications are
increasing across the globe.
The market may be explored
by product, technology, workflow, disease area, applications, end users, and
geography. Single-cell genome sequencing Market may be explored by product as
Instruments, and Reagents. The “Instrument” segment dominated the Single-cell
genome sequencing in 2016 and is anticipated to maintain its dominance by 2025.
Growth and implementation of technically progressive solutions and instruments
is anticipated to propel the development of the segment in the years to come.
The market may be explored
by Technology as MDA, PCR, qPCR, Microarray, and NGS. The NGS segment is
dominated the segment technology of the Single-cell genome sequencing in 2016.
And it is anticipated to maintain its dominance by 2025. Single-cell genome
sequencing Market may be explored by workflow as Sample preparation, Isolation,
and Genomic analysis. Single-cell genome sequencing Market may be explored by
disease as Immunology, Cancer, Prenatal diagnosis, Microbiology, Neurobiology,
and Others.
The “Cancer” segment
dominated the market in 2016 and anticipated to maintain its dominance by 2025.
Growing occurrence of colorectal, breast cancer and prostate are poised to
generate profitable development opportunities. Single-cell genome sequencing
Market may be explored by applications as Differentiation/ reprogramming,
Subpopulation characterization, Genomic variation, CTCs, and Others. The CTCs
segment dominated the Single-cell genome sequencing in 2016 and is anticipated
to maintain its dominance by 2025.
The market may be explored
by end users as Biotechnology & biopharmaceutical companies, Clinics,
Academic & Research Laboratories, and Others. North America accounted for
the major share of the global Single-cell genome sequencing Market Size
Analysis in 2016 and will continue to rule the roost in the forecast period.
Some of the key players
that fuel the development of the Single-cell genome sequencing Industry
includes Agilent Technologies Inc, 10X Genomics, Johnson & Johnson, DNA
Electronics Ltd., Zephyrus Biosciences Inc., Thermo Fisher Scientific Inc. The
leading companies are taking up partnerships, mergers and acquisitions, and
joint ventures in order to boost the inorganic growth of the industry.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment